In this article we will analyze the relevance of Flutazolam in today's society. Flutazolam has become a topic of great interest and debate in recent years, generating conflicting opinions and different positions. Throughout history, Flutazolam has played a fundamental role in various aspects of daily life, from economics to culture, politics and technology. In this sense, it is crucial to examine in detail the influence of Flutazolam on our daily lives and on the development of society as a whole. Additionally, we will explore the future implications of Flutazolam and its impact on the modern world.
Clinical data | |
---|---|
Trade names | Coreminal (JP) |
Other names | 13-chloro- 2-(2-fluorophenyl)- 9-(2-hydroxyethyl)- 3-oxa- 6,9-diazatricyclo tetradeca-1(10),11,13- trien- 8-one |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 3.5 hours (parent compound); 47-100 hours (major metabolite) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H18ClFN2O3 |
Molar mass | 376.81 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Flutazolam (Coreminal, MS-4101) is a drug which is a benzodiazepine derivative. It was invented in Japan, and this is the main country in which it has been used medically. It has sedative, muscle relaxant, anticonvulsant, and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and though it is around the same potency as diazepam, it produces a more marked sedation and impaired coordination. It is indicated for the treatment of insomnia. Its major active metabolite is n-desalkylflurazepam, also known as norflurazepam, which is also a principal metabolite of flurazepam (trade name Dalmane). While flutazolam has a very short half-life of only 3.5 hours, n-desalkylflurazepam has a long half-life of between 47–100 hours.
Flutazolam is closely related in structure to another benzodiazepine, haloxazolam.